Biomarkers /

CCDC170

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
6q25.1
Protein [2]
Coiled-coil domain-containing protein 170
Synonyms [1]
bA282P11.1, C6orf97

CCDC170 is altered in 0.09% of all cancers with breast invasive ductal carcinoma, invasive breast carcinoma, high grade ovarian serous adenocarcinoma, endometrial serous adenocarcinoma, and colon adenocarcinoma having the greatest prevalence of alterations [3].

CCDC170 GENIE Cases - Top Diseases

The most common alterations in CCDC170 are CCDC170-ESR1 Fusion (0.03%) and CCDC170 Fusion (0.02%) [3].

CCDC170 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.